Literature DB >> 11123048

Sympathetic nervous system function in fibromyalgia.

F Petzke1, D J Clauw.   

Abstract

This review focuses on studies of the sympathetic nervous system in fibromyalgia (FM). First, a brief review of the sympathetic system, and its relationship to the human stress response, is outlined. Then various studies of functional assessment of sympathetic function in FM are highlighted. Certain methods of assessment (eg, heart rate variability, biochemical, and psychophysical responses to various stressors) that we believe to be of specific importance for future research are discussed in greater detail. Finally, findings on autonomic function in related disorders--specifically, chronic fatigue syndrome, irritable bowel syndrome, and migraine--will be briefly presented.

Entities:  

Mesh:

Year:  2000        PMID: 11123048     DOI: 10.1007/s11926-000-0051-5

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  60 in total

Review 1.  Time domain measurements of heart rate variability.

Authors:  R E Kleiger; P K Stein; M S Bosner; J N Rottman
Journal:  Cardiol Clin       Date:  1992-08       Impact factor: 2.213

Review 2.  Descending noradrenergic influences on pain.

Authors:  S L Jones
Journal:  Prog Brain Res       Date:  1991       Impact factor: 2.453

3.  Orthostatic sympathetic derangement in subjects with fibromyalgia.

Authors:  M Martínez-Lavín; A G Hermosillo; C Mendoza; R Ortiz; J C Cajigas; C Pineda; A Nava; M Vallejo
Journal:  J Rheumatol       Date:  1997-04       Impact factor: 4.666

4.  Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis.

Authors:  Henning Vaerøy; Robert Helle; Øystein Førre; Erik Kåss; Lars Terenius
Journal:  Pain       Date:  1988-01       Impact factor: 6.961

Review 5.  The anatomy and biochemistry of headache.

Authors:  M G Buzzi; M Bonamini; R Cerbo
Journal:  Funct Neurol       Date:  1993 Nov-Dec

6.  Modulation of pressure pain thresholds during and following isometric contraction in patients with fibromyalgia and in healthy controls.

Authors:  Eva Kosek; Jan Ekholm; Per Hansson
Journal:  Pain       Date:  1996-03       Impact factor: 6.961

Review 7.  Neuropeptide Y and sympathetic neurotransmission.

Authors:  J M Lundberg; A Franco-Cereceda; J S Lacroix; J Pernow
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

Review 8.  Neuroendocrinology of stress: implications for growth and development.

Authors:  C A Stratakis; P W Gold; G P Chrousos
Journal:  Horm Res       Date:  1995

9.  Noradrenergic inhibition of the release of substance P from the primary afferents in the rabbit spinal dorsal horn.

Authors:  Y Kuraishi; N Hirota; Y Sato; S Kaneko; M Satoh; H Takagi
Journal:  Brain Res       Date:  1985-12-16       Impact factor: 3.252

Review 10.  Neuropeptide Y. A novel sympathetic stress hormone and more.

Authors:  Z Zukowska-Grojec
Journal:  Ann N Y Acad Sci       Date:  1995-12-29       Impact factor: 5.691

View more
  9 in total

1.  Potential autonomic risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study.

Authors:  William Maixner; Joel D Greenspan; Ronald Dubner; Eric Bair; Flora Mulkey; Vanessa Miller; Charles Knott; Gary D Slade; Richard Ohrbach; Luda Diatchenko; Roger B Fillingim
Journal:  J Pain       Date:  2011-11       Impact factor: 5.820

2.  Patient-derived determinants for participation in placebo-controlled clinical trials for fibromyalgia.

Authors:  Andrew J Holman; Moni Blazej Neradilek; David D Dryland; Richard A Neiman; Paul B Brown; Robert E Ettlinger
Journal:  Curr Pain Headache Rep       Date:  2010-12

Review 3.  Neurobiology of fibromyalgia and chronic widespread pain.

Authors:  Kathleen A Sluka; Daniel J Clauw
Journal:  Neuroscience       Date:  2016-06-09       Impact factor: 3.590

4.  Similarities in stress physiology among patients with chronic pain and headache disorders: evidence for a common pathophysiological mechanism?

Authors:  Rune Bang Leistad; Kristian Bernhard Nilsen; Lars Jacob Stovner; Rolf Harald Westgaard; Magne Rø; Trond Sand
Journal:  J Headache Pain       Date:  2008-03-29       Impact factor: 7.277

Review 5.  Fibromyalgia: A Critical and Comprehensive Review.

Authors:  Andrea T Borchers; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

6.  The clinical concept of fibromyalgia as a changing paradigm in the past 20 years.

Authors:  Mary-Ann Fitzcharles; Muhammad B Yunus
Journal:  Pain Res Treat       Date:  2011-10-29

7.  Relationships of autonomic dysfunction with disease severity and neuropathic pain features in fibromyalgia: is it really a sympathetically maintained neuropathic pain?

Authors:  Arzu Yagiz On; Goksel Tanigor; Dilek Aykanat Baydar
Journal:  Korean J Pain       Date:  2022-07-01

8.  Interplay between genetics and lifestyle on pain susceptibility in women with fibromyalgia: the al-Ándalus project.

Authors:  Fernando Estévez-López; Juan M Guerrero-González; Diego Salazar-Tortosa; Daniel Camiletti-Moirón; Blanca Gavilán-Carrera; Virginia A Aparicio; Pedro Acosta-Manzano; Inmaculada C Álvarez-Gallardo; Víctor Segura-Jiménez; Alberto Soriano-Maldonado; Rinie Geenen; Manuel Delgado-Fernández; Luis J Martínez-González; Jonatan R Ruiz; María J Álvarez-Cubero
Journal:  Rheumatology (Oxford)       Date:  2022-08-03       Impact factor: 7.046

9.  Effects of naltrexone on pain sensitivity and mood in fibromyalgia: no evidence for endogenous opioid pathophysiology.

Authors:  Jarred W Younger; Alex J Zautra; Eric T Cummins
Journal:  PLoS One       Date:  2009-04-13       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.